首页> 美国卫生研究院文献>PLoS Clinical Trials >Nfkb1 Inhibits LPS-Induced IFN-β and IL-12 p40 Production in Macrophages by Distinct Mechanisms
【2h】

Nfkb1 Inhibits LPS-Induced IFN-β and IL-12 p40 Production in Macrophages by Distinct Mechanisms

机译:Nfkb1通过不同的机制抑制巨噬细胞中LPS诱导的IFN-β和IL-12 p40的产生。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background Nfkb1-deficient murine macrophages express higher levels of IFN-β and IL-12 p40 following LPS stimulation than control macrophages, but the molecular basis for this phenomenon has not been completely defined. Nfkb1 encodes several gene products including the NF-κB subunit p50 and its precursor p105. p50 is derived from the N-terminal of 105, and p50 homodimers can exhibit suppressive activity when overexpressed. The C-terminal region of p105 is necessary for LPS-induced ERK activation and it has been suggested that ERK activity inhibits both IFN-β and IL-12 p40 following LPS stimulation. However, the contributions of p50 and the C-terminal domain of p105 in regulating endogenous IFN-β(Ifnb) and IL-12 p40 (Il12b) gene expression in macrophages following LPS stimulation have not been directly compared.
机译:背景Nfkb1缺陷型鼠巨噬细胞在LPS刺激后比对照巨噬细胞表达更高水平的IFN-β和IL-12 p40,但这种现象的分子基础尚未完全确定。 Nfkb1编码几种基因产物,包括NF-κB亚基p50及其前体p105。 p50源自105的N端,p50同型二聚体在过表达时可表现出抑制活性。 p105的C端区域对于LPS诱导的ERK激活是必需的,并且有人提出,在LPS刺激后,ERK活性会抑制IFN-β和IL-12 p40。然而,尚未直接比较p50和p105的C末端结构域对LPS刺激后巨噬细胞内源性IFN-β(Ifnb)和IL-12 p40(Il12b)基因表达的调节作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号